Analysis of Influencing Factors of Early Rejection after Heart Transplantation
-
摘要:
目的 探讨HLA配型与心脏移植患者术后急性排斥反应的关系。 方法 纳入 2003年5月至2021年1月,在昆明医科大学附属延安医院做心脏移植术的24例患者作为研究对象,对移植术后3至12个月的患者早期疗效和排斥反应进行随访观察。使用PCR-SSP方法对供受者进行HLA分型。采用SPSS Statistics 17.0软件的Forward Stepwise (Conditional)方法进行二分类逻辑回归,分析心脏移植患者急性排斥的影响因素。 结果 对24例心脏移植供受者之间的HLA六抗原配型,在错配数3至4个抗原以内与错配数5或6个抗原相比,排异反应率低差异具有统计学意义(P < 0.05)。在2例按照ABO血型相容原则,O型供体心脏移植给A型受体的病例中,2例早期均发生了排斥反应,而在7例性别不同的供受者中有3例早期有排异反应。 结论 多方面因素会造成心脏移植的排斥反应,而HLA六抗原错配数是心脏移植排斥反应的重要因素之一。 Abstract:Objective To analyze and explore the relationship between HLA matching and acute rejection after the heart transplantation. Methods From May 2003 to January 2021, 24 patients who underwent heart transplantation in Yan’an Hospital affiliated to Kunming Medical University were included as the research subjects. Follow-up observations were made on the early curative effect and rejection of patients 3 to 12 months after transplantation. HLA typing was performed by PCR-SSP and the forward stepwise (conditional) method of SPSS statistics 17.0 software was used for binary logistic regression to analyze the influencing factors of acute rejection in heart transplantation patients. Results For the HLA six-antigen matching between the 24 donors and recipients of heart transplantation, the rejection rate was lower when the number of mismatches was less than 3 to 4 compared with the number of mismatches of 5 or 6 antigens (P < 0.05) The difference was statistically significant. According to the principle of ABO blood group compatibility, in 2 cases of type O donor heart transplantation to type A recipients, both of the 2 cases had the early rejection, while 3 of the 7 donors and recipients of different genders had the early rejection. Conclusion Many factors can cause the rejection of heart transplantation, and the number of HLA six antigen mismatches is one of the important factors for the rejection of heart transplantation. -
Key words:
- Heart transplantation /
- HLA matching /
- Blood type /
- Gender /
- Transplant rejection
-
表 1 六抗原错配、DR错配、性别错配、血型错配 二分类数据
Table 1. Six classification data of antigen mismatch,DR mismatch,sex mismatch and blood type mismatch
编号 排斥情况 性别错配 血型错配 六抗原错配 DR错配 1 0 0 0 0 0 2 0 1 0 0 0 3 0 0 0 0 1 4 1 1 1 1 0 5 1 0 1 1 1 6 1 0 0 1 1 7 0 0 0 0 0 8 1 1 0 1 1 9 0 0 0 0 0 10 0 0 0 0 1 11 1 1 1 1 1 12 0 0 0 0 0 13 0 1 0 0 0 14 0 0 0 0 0 15 0 1 0 0 0 16 0 0 0 0 1 17 0 1 0 0 0 18 0 1 0 0 0 19 0 0 0 0 0 20 0 1 0 0 0 21 0 0 0 0 0 22 0 0 0 0 1 23 0 0 0 0 0 24 1 1 0 1 1 注:0:无排斥;1:排斥。 表 2 排斥反应变量情况
Table 2. The rejection variable
不在方程中的变量 得分 df Sig. 步骤 0 变量 性别错配 2.057 1 0.151 血型错配 10.286 1 0.001 六抗原错配 24 1 0 DR错配 7.17 1 0.007 总统计量 24 4 0 -
[1] 孟莹,张毛毛. 平衡免疫抑制剂在心脏移植中的关键作用[J]. 心血管康复医学杂志,2020,29(5):645-647. doi: 10.3969/j.issn.1008-0074.2020.05.31 [2] 张正刚 郑芳. 心脏移植物血管病变研究进展[J]. 器官移植,2020,11(1):104-109. doi: 10.3969/j.issn.1674-7445.2020.01.017 [3] TENDERIcH G,KOERNER M M,STuETTGEN B,et a1. Pre-existing elevated pulmonary vascular resistance:Long-term hemodynamic follow-up and outcome of recipients after orthotopic heart transplantation[J]. Cardiovasc Surg,2000,41(2):215-219. [4] 胡盛寿,王春生,董念国. 心脏移植的多中心研究[J]. 中华器官移植杂志,2012,33(5):264-266. doi: 10.3760/cma.j.issn.0254-1785.2012.05.002 [5] Pei R,Lee J H,Shih N J,et al. Single human leukocyte antigenflow cytometry beads for accurate identification of human leukocyteantigen antibody specificities[J]. Transplantation,2003,75(1):43-49. doi: 10.1097/00007890-200301150-00008 [6] Stiller C R,Sinclair N R,Abrahams S,et al. Lymphocytedependentantibody and renal graft rejection[J]. Lancet,1971(7913):953-954. [7] YUsEN R D,EDwARDs L B,DIPcHAND A I,et a1. Registry of the internatinal society for heart and 1ung transplantation:33rd adult 1ung and heart-1ung transplant report-2016;Focus theme:Primary diagnostic indicatins for transplant[J]. Heart Lung Transplant,2016,35(10):1185-1195. doi: 10.1016/j.healun.2016.08.018 [8] 孙菲菲,房孝生,姜玉杰,等. 57例急性淋巴细胞白血病异基因造血干细胞移植后抗宿主病的发生及影响因素分析[J]. 山东大学学报:医学版,2019,57(7):61-66. [9] 赵子进,霍治,陈璐瑶. 同种异体心脏移植中急性排斥反应免疫学机制及进展[J]. 现代生物医学进展,2009,9(23):4587-4589. [10] TAYLOR D O,EDWARDS L B,BoUCEK M M,et a1. Registry of the international society for heart and lung transplantation:Twenty-third offlcial adult heart transplantation report-2006[J]. Heart Lung Transplant,2006,25(8):869-879. doi: 10.1016/j.healun.2006.05.002 [11] Avery R K. Cardiac-allograft vasculopathy[J]. N Engl J med,2003,349(9):829-830. doi: 10.1056/NEJMp038124 [12] Itescu,Silviu,Tung,C M Thomas,Burke E M,et al. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients[J]. Lancet,1998,352(1):263-270. [13] 姜兆磊. 心脏移植物血管病变的临床研究现状[J]. 国际心血管病杂志,2011,38(1):41-43. doi: 10.3969/j.issn.1673-6583.2011.01.012 [14] 薛梅,梁涛,邱建丽,等. 心脏移植受者生存质量现状的研究[J]. 中华护理杂志,2014,49(8):924-927. [15] 杨建飞, 魏来, 周亚滨. 心脏移植慢性排斥反应的免疫学研究进展 [J]. 求医问药, 2013, 11(4): 334-344 [16] Caro-Oleas J L,González-Escribano M F,González-Roncero F M,et al. Clinical relevance of HLA donor-specific antibodies detectedby single antigen assay in kidney transplantation[J]. Nephrol Dial Transplant,2012,27(3):1231-1238. [17] Tait B D,Süsal C,Gebel H M,et al. Consensus guidelines on the testing and clinical management issues associated with HLA and Non-HLA antibodies in transplantation[J]. Transplantation,2013,95(1):19-47. doi: 10.1097/TP.0b013e31827a19cc